At the USC Roski Eye Institute, researchers Melinda Chang, MD, a pediatric neuro-ophthalmologist and Benjamin Xu, MD, PhD, who specializes in glaucoma, are leading research on the effectiveness of artificial intelligence in the field of eye care.

While they’re running separate studies specific to their pursuits, both hope that AI will be able to automate clinical tasks, streamline health care services and provide high-quality care for patients in need. This would give doctors time to see a greater number of patients, expanding patient access and reducing wait times for people with progressive eye conditions that require early treatment.

To read the full story, click here.